Dr. Anglesio is an assistant professor in the Department of Obstetrics and Gynecology at the University of British Columbia (UBC) and a principle investigator with OVCARE, BC’s Gynecological Cancer Research Team. Dr. Anglesio trained in Microbiology and Immunology at McGill University and received his PhD in Experimental Pathology with Dr. Poul Sorensen at UBC. He went on to study highthroughput genomics with Dr. David Bowtell at the Peter MacCallum Cancer Centre in Melbourne, Australia. He returned to Vancouver, joining Dr. David Huntsman and OVCARE in 2010, focusing on type-specific ovarian cancer research and biomarker validation.
Dr. Anglesio has been a faculty member at UBC since early 2017 and has been supervising graduate and undergraduate students and mentoring junior researchers with OVCARE, since 2010. Dr. Anglesio has led several studies defining the distinct genomics between ovarian cancer types including landmark studies reclassifying cell lines for type specific ovarian cancer research, and defining common recurrent molecular changes in rare ovarian subtypes including mucinous, clear cell, endometrioid histotypes. His report identifying recurrent cancer-driver mutations in nonmalignant endometriosis was recognized as the most impactful publication in the field of obstetrical and gynecologic and breast disease of 2017 by the Columbia Hospital for Women Research Foundation (CHWRF). His lab is now focused on uncovering disease and phenotype biomarkers in both endometriosis and endometriosis-associated cancers as well as exploring the mechanisms through which endometriosis may undergo malignant transformation.
For an up-to-date list of publications by Dr. Anglesio, please see NCBI.